Delivery Order SPE2DR25D9316-SPE2DR26FSCE8
- Not listed
- The Defense Logistics Agency issued a delivery order valued at $14,962.50 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of FASENRA PEN 30 MG/ML. This firm fixed-price delivery order, awarded on January 5, 2026, with an ultimate completion date of January 6, 2026, was issued without a set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. The award...
- The Defense Logistics Agency awarded a $19,950 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for FASENRA PEN 30 MG/ML. The award, issued on January 7, 2026, with an ultimate completion date of January 8, 2026, carries no set-aside designation, indicating the vendor competed in unrestricted federal procurement. DMS Pharmaceutical Group is performing work at its Park Ridge facility and...
- The Defense Logistics Agency awarded a $7,481.25 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of FASENRA Pen 30 mg/mL. The delivery order, issued on January 23, 2026, with an ultimate completion date of January 26, 2026, carries no set-aside designation, indicating the awardee competed successfully in unrestricted federal procurement. This delivery order was issued under...
- The Defense Logistics Agency awarded a $4,987.50 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for FASENRA PEN 30 MG/ML. The award, issued on January 20, 2026, with an ultimate completion date of January 21, 2026, carries no set-aside designation, indicating the vendor competed in unrestricted federal procurement. This delivery order is issued under DMS Pharmaceutical Group's Indefinite...
- The Defense Logistics Agency has awarded a delivery order valued at $9,774.00 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of FASENRA 30 mg/ml syringes. DMS Pharmaceutical Group Inc. is a critical supplier within the federal pharmaceutical supply chain and has been registered in the System for Award Management since 2001. This delivery order was issued without a set-aside designation, reflecting the...
- The Defense Logistics Agency awarded a delivery order valued at $2,493.75 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Fasenra Pen 30 mg/mL. This firm fixed-price delivery order, issued on January 20, 2026, with an ultimate completion date of January 21, 2026, was awarded without a set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement....
- The Defense Logistics Agency awarded a $13,167 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for FASENRA PEN 30 MG/ML. The award was issued on January 22, 2026, with an ultimate completion date of January 23, 2026, under a firm fixed-price contract structure with no set-aside designation. DMS Pharmaceutical Group is performing the work at its Park Ridge, IL location. This delivery order represents...
- The Defense Logistics Agency awarded a $4,987.50 firm fixed-price delivery order for FASENRA Pen 30 mg/ml to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This delivery order, issued on January 9, 2026 with an ultimate completion date of January 12, 2026, carries no set-aside designation, indicating the vendor competed in unrestricted federal procurement. The award is issued under DMS Pharmaceutical Group's larger...
- The Defense Logistics Agency awarded a $29,925 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Fasenra Pen 30 mg/ml. This firm fixed-price delivery order, issued on January 13, 2026, with an ultimate completion date of January 14, 2026, was awarded without a set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. The contract...
- The Defense Logistics Agency awarded a delivery order valued at $2,493.75 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for FASENRA Pen 30 MG/ML. The award, issued on January 9, 2026, with an ultimate completion date of January 12, 2026, utilizes firm fixed-price pricing with no set-aside designation. This delivery order falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense...
- SPE2DR25D9316Indefinite Delivery Contract
- SPE2DR25D9316-SPE2DR26FSCE8Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $24,937.50 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of FASENRA PEN 30 MG/ML. This firm fixed-price delivery order, issued on January 23, 2026, with an ultimate completion date of January 26, 2026, was awarded without a set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. The award falls under DMS Pharmaceutical Group's Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to provide comprehensive pharmaceutical and medical supply support to Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group Inc. has established itself as a critical supplier within the federal pharmaceutical supply chain since its SAM registration in 2001, with demonstrated performance across diverse therapeutic categories including specialty biologics, oncology treatments, vaccines, and routine pharmaceuticals. As a regional prime vendor contractor under the PPV-G GEN V program with a parent contract ceiling of $499,999,999 extending through December 31, 2036, the company is positioned to fulfill recurring medical supply requirements for military healthcare operations globally. The Defense Logistics Agency's Medical Supply Chain division continues to leverage DMS Pharmaceutical Group's capabilities across multiple delivery orders to support the broad pharmaceutical needs of the Department of Defense.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $24.9k | 1/22/26 |